Title : Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.

Pub. Date : 2020

PMID : 32735623






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PFS-2/PPS medians gradually increased in monoCT, 2.6/5.1 months; polyCT 3.4/6.3 months; ramucirumab+CT, 4.1/6.5 months; platinum-reintroduction, 4.2/6.7 months, and for the HER2+ subgroup in particular, trastuzumab+CT, 5.2/11.7 months. Platinum erb-b2 receptor tyrosine kinase 2 Homo sapiens